{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:49:28Z","timestamp":1781502568484,"version":"3.54.1"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2016,3,15]]},"abstract":"<jats:p>Selection of lung cancer treatment should be based on tumour characteristics, physiological reserves and preferences of the patient. Our aims were to identify and quantify other factors associated with treatment received. Lung cancer patient data from 2002 to 2011 were obtained from the national population\u2010based Cancer Registry of Norway, Statistics Norway and the Norwegian Patient Register. Multivariable logistic regression examined whether year of diagnosis, age, sex, education, income, health trust, smoking status, extent of disease, histology and comorbidities were associated with choice of treatment; surgery or radical or palliative radiotherapy, within 1 year of diagnosis. Among the 24,324 lung cancer patients identified, the resection rate remained constant while the proportion of radical radiotherapy administered increased from 8.6 to 14.1%. Older patients, those with lower household incomes and certain health trusts were less likely to receive any treatment. Lower education and the male gender were identified as negative predictors for receiving surgery. Smoking history was positively associated with both radical and palliative radiotherapy, while comorbidity and symptoms were independently associated with receiving surgery and palliative radiotherapy. Although Norway is a highly egalitarian country with a free, universal healthcare system, this study indicates that surgery and radical and palliative radiotherapy were under\u2010used among the elderly, those with a lower socioeconomic status and those living in certain health trusts.<\/jats:p>","DOI":"10.1002\/ijc.29875","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T16:03:51Z","timestamp":1443629031000},"page":"1350-1360","source":"Crossref","is-referenced-by-count":49,"title":["Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage"],"prefix":"10.1002","volume":"138","author":[{"given":"Yngvar","family":"Nilssen","sequence":"first","affiliation":[{"name":"Department of Registration Cancer Registry of Norway Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond\u2010Eirik","family":"Strand","sequence":"additional","affiliation":[{"name":"Department of Registration Cancer Registry of Norway Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fjellbirkeland","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine Oslo University Hospital Oslo Norway"},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Bartnes","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Respiratory Medicine University Hospital North Norway Troms\u00f8 Norway"},{"name":"Institute of Clinical Medicine, UiT \u2010the Arctic University of Norway Troms\u00f8 Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odd Terje","family":"Brustugun","sequence":"additional","affiliation":[{"name":"Department of Oncology Oslo University Hospital \u2013 the Norwegian Radium Hospital Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne L","family":"O'Connell","sequence":"additional","affiliation":[{"name":"Cancer Research Division Cancer Council NSW Sydney NSW Australia"},{"name":"School of Public Health University of Sydney Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Qin","family":"Yu","sequence":"additional","affiliation":[{"name":"Cancer Research Division Cancer Council NSW Sydney NSW Australia"},{"name":"School of Public Health University of Sydney Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Registration Cancer Registry of Norway Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"The Norwegian Directorate of Health. [Nasjonalt handlingsprogram med retningslinjer for diagnostikk behandling og oppfolgning av lungekreft]. Oslo.2014."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2014.08.031"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.09.006"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001376"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja14.00365"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.310"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.07.012"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs002"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001048"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.05.011"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.01.008"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.037"},{"key":"e_1_2_7_14_1","first-page":"782","volume-title":"Cancer Indidence in Five Continents, vol. VIII","author":"Parkin DM","year":"2002"},{"key":"e_1_2_7_15_1","unstructured":"U.S. Department of Health and Human Services. SEER program: comparative staging guide for cancer. U.S. Department of Health and Human Services Bethesda MD 1993."},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.06.059"},{"key":"e_1_2_7_17_1","unstructured":"National Quality Register for Lung Cancer. [Aarsrapport 2014]. Oslo: Cancer Registry of Norway 2014."},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S70742"},{"key":"e_1_2_7_20_1","volume-title":"Stata Statistical Software: Release 13","author":"StataCorp.","year":"2013"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1999.10474144"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.125914"},{"key":"e_1_2_7_24_1","unstructured":"Tal om tobakk 1973\u20102012 [database on the Internet]. Available at:https:\/\/helsedirektoratet.no\/Lists\/Publikasjoner\/Attachments\/319\/Tal\u2010om\u2010tobakk\u20101973\u20102012\u2010IS\u20102064.pdf. Accessed on July 2 2015."},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2004.023531"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2014.1001037"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2010.06.020"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2012.06.006"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605257"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.01.050"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.11.023"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2011.158972"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.9666"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)00440-5"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.7954"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.04.059"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.03.050"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2012.000835"},{"key":"e_1_2_7_39_1","unstructured":"GINI Index. Available at:http:\/\/data.worldbank.org\/indicator\/SI.POV.GINI\/. Accessed 7 Oct 2015."}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.29875","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.29875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:16:43Z","timestamp":1696335403000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.29875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,3,15]]}},"alternative-id":["10.1002\/ijc.29875"],"URL":"https:\/\/doi.org\/10.1002\/ijc.29875","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}